COMMANDS Luspatercept
COMMANDS: Long-term Outcomes of the Phase III Trial of Luspatercept vs Epoetin alfa for ESA-Naive, Transfusion-Dependent, Lower-Risk MDS

Released: December 09, 2024

Expiration: December 08, 2025

Activity

Progress
1
Course Completed